Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04679844 · ClinicalTrials.gov registry record · NA
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
A NA study of Degenerative Disc Disease and Back Pain, sponsored by Kuros Biosurgery.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 6
- Study locations
NCT04679844 is a NA study of Degenerative Disc Disease and Back Pain that is actively recruiting participants, run by Kuros Biosurgery. The registered enrollment target is 60 participants, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (64% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT04679844, a NA study of Degenerative Disc Disease and Back Pain, is actively recruiting participants, sponsored by Kuros Biosurgery.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a phase IV post-marketing study for MagnetOs Easypack Putty. MagnetOs Easypack Putty is a synthetic bone graft extender product that is routinely used by surgeons as a treatment for patients with degenerative disc disease or spinal trauma undergoing spinal fusion surgery. In this study, MagnetOs Easypack Putty will be used according to the latest U.S. Instructions For Use, standalone in the posterolateral spine.
Conditions Studied
Interventions
- DEVICE MagnetOs Easypack Putty
- DEVICE Demineralized Bone Matrix or Fibers mixed with local autograft bone
Study Locations (6)
California
- The Regents of the University of California- Irvine Campus - Irvine
Michigan
- Corewell Health - Grand Rapids
Missouri
- The Washington University - St Louis
Pennsylvania
- Rothman Orthopaedic Institute - Philadelphia
Tennessee
- Tennessee Orthopaedic Alliance - Nashville
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-12-06 |
| Est. Completion | 2027-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04679844
The ClinicalTrials.gov registry entry for NCT04679844 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (64% lower). The listed sponsor is Kuros Biosurgery, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 2 interventions - of which MagnetOs Easypack Putty is the first listed.
NCT04679844 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Michigan, Missouri.
Frequently Asked Questions
What is clinical trial NCT04679844 about?
NCT04679844 is a clinical study titled "Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion". This is a phase IV post-marketing study for MagnetOs Easypack Putty. MagnetOs Easypack Putty is a synthetic bone graft extender product that is routinely used by surgeons as a treatment for patients with degenerative disc disease or spinal trauma undergoing spinal fusion surgery. In this study, Mag...
What is the current status of trial NCT04679844?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-12-06. Estimated completion is 2027-08-30.
What conditions does trial NCT04679844 study?
This clinical trial studies the following conditions: Degenerative Disc Disease, Back Pain, Spine Fusion.
What interventions are being tested in trial NCT04679844?
The interventions under investigation include: MagnetOs Easypack Putty (DEVICE), Demineralized Bone Matrix or Fibers mixed with local autograft bone (DEVICE).
Who is sponsoring clinical trial NCT04679844?
This trial is sponsored by Kuros Biosurgery, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04679844 being conducted?
This trial has 6 study locations across California, Michigan, Missouri, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
-
Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
RECRUITING · NA
-
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
RECRUITING · NA
-
ACDF Using Structural Allograft vs. Tritanium C
RECRUITING · NA
-
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.